<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Corixa Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
21887F100
- --------------------------------------------------------------------------------
(CUSIP Number)
Donald F. Parman, SmithKline Beecham Corporation
One Franklin Plaza, Philadelphia, PA 19102
Telephone 215-751-7633
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
November 30, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
SCHEDULE 13D
CUSIP NO. 21887F100
PAGE 2 OF 7 PAGES
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.R. One, Limited
23-1729901
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E)
/ /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania Business Trust
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 505,050
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
505,050
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
505,050
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.9%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
<PAGE> 3
SCHEDULE 13D
CUSIP NO. 21887F100 PAGE 3 OF 7 PAGES
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SmithKline Beecham plc
98-0101920
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) / /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
England
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 427,807
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
427,807
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
427,807
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.3%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 4
Page 4 of 7 Pages
Item 1. Security and Issuer.
Common Stock, $.001 Par Value
Corixa Corporation
1124 Columbia St., Suite 200
Seattle, WA 98104
Item 2. Identity and Background.
(a) S.R. One, Limited ("SRO"), a Pennsylvania business trust, is a
venture capital company.
SmithKline Beecham plc (SBplc), a company organized under the laws of
England, discovers, develops, manufactures and markets pharmaceuticals,
vaccines, over-the-counter medicines and health-related products, and the
provision of healthcare services including clinical laboratory testing, disease
management, and pharmaceutical benefit management.
Collectively, SRO and SBplc are sometimes referred to as the "Group".
(b) The principal business address for SRO is:
Four Tower Bridge
200 Barr Harbor Drive, Suite 250
West Conshohocken, PA 19428-2977
The principal business address for SBplc is:
New Horizons Court
Brentford
Middlesex
ENGLAND TW8 9EP
(c) Information concerning the Group is set forth in response to
Item 2(a) above.
(d) During the last five years, the Group has not been convicted in a
criminal proceeding, excluding traffic violations or similar misdemeanors.
(e) During the last five years the Group was not a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and as
a result thereof subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to Federal or
State securities laws or finding any violation with respect to such laws.
(f) Not applicable.
<PAGE> 5
Page 5 of 7 Pages
Item 3. Source and Amount of Funds or Other Consideration.
In May 1996, SRO purchased 1,666,667 shares of Series B Preferred stock
for $5,000,001 in a private placement. In connection with the Issuer's initial
public offering ("IPO") in October 1997, SRO received 505,050 shares of Common
stock upon the conversion of its Series B Preferred stock. On November 30, 1998
SBplc purchased 427,807 shares of Common stock for $2,499,997 in a private
placement. In each case, the source of funds is Working Capital.
Item 4. Purpose of Transaction.
The Group intends to review from time to time the business affairs and
financial position of the Issuer. Based on such evaluation and review, as well
as general economic and industry conditions existing at the time and the Group's
own financial plans, the Group may consider from time to time various
alternative courses of action. Such actions may include the acquisition of
additional shares through open market purchases, privately negotiated
transactions or otherwise. Alternatively, such actions may involve the sale of
all or a portion of the shares in the open market, in privately negotiated
transactions, through public offering or otherwise. All of the securities
acquired have been purchases for investment purposes.
Item 5. Interest in Securities of the Issuer.
(a) Amount and Percent Beneficially Owned
Registered Name No. of Shares Percent
--------------- ------------- -------
SRO 505,050 3.9%
SBplc 427,807 3.3%
------- ----
932,857 7.2%
(b) The respective members of the Group have sole power to vote and
to dispose of all of the shares of Common Stock identified in subparagraph (a)
above.
(c) In May 1996, SRO purchased 1,666,667 shares of Series B Preferred
stock for $5,000,001 in a private placement. These shares were converted into
505,050 shares of Common stock following Issuer's IPO in October 1997. Pursuant
to a Collaboration and License Agreement ("Agreement") dated October 28, 1998
between SBplc and Issuer, SBplc acquired 427,807 shares of Common Stock for an
acquisition price of $2,499,997. In addition, the Agreement provides that Issuer
may require SBplc to purchase an additional $2.5 million worth of Corixa common
stock at a premium to market.
(d) The only transactions involving the Group and the Common Stock of
the Issuer are the transactions referenced above.
(e) Not applicable
<PAGE> 6
Page 6 of 7 Pages
Item 6. Contracts, Arrangements, Understandings or Relationship With respect
to Securities of the Issuer.
None
Item 7. Materials to be Filed as Exhibits.
Exhibit 1. Joint Filing Agreement dated as of February 1, 1999
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
the undersigned certifies that the information set forth in the Statement is
true, correct and complete.
DATED: February 1, 1999 S.R. ONE, LIMITED
By: /s/ Donald F. Parman
Donald F. Parman
Vice President
and Secretary
<PAGE> 7
Page 7 of 7 Pages
EXHIBIT 1
The undersigned hereby agree, pursuant to Rule 13d-1(f)(1) under Section
13(d) of the Securities Exchange Act of 1934, as amended, that (1) they shall
cause a single Schedule 13D to be filed on behalf of both parties in respect
of their ownership interests in the Common Stock of Corixa Corporation and (2)
S.R. One, Limited shall be authorized to sign said Schedule 13D and any
amendments thereto on behalf of both members of the Group.
S.R. ONE, LIMITED
By:/s/ Donald F. Parman
------------------------
Donald F. Parman
Vice President
and Secretary
SMITHKLINE BEECHAM plc
By: /s/ Clare McClintock
------------------------
Clare McClintock
Assistant Secretary
DATED: February 1, 1999
--------------------
